Live Quote · NYSEABBVHealthcare· Drug Manufacturers - General

AbbVie Inc.

$288.71▼ 1.41%($-4.11)
MKT CAP $510.32BNEXT EARNINGS Feb 3, 2027
50%
Bullish
TickerSpark Score
65/100
▌ Solid
60
Valuation
70
Profitability
40
Growth
56
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ABBV research report →

Analyst Price Target
$313.80+8.7% vs. today

Range $275 – $340

Analyst RatingBuy
31 Buy12 Hold1 Sell

Price Chart

+23.30% · this period
$295.03$246.20$197.38Nov 18May 21Nov 18
52-Week Range87% of range
Low
$190.75
Current
$288.71
High
$302.93

AI analysis · Last refreshed November 17, 2026 · Live quote · Not investment advice